Cargando…

Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis

The current serological test for human onchocerciasis relies on IgG4 reactivity against the parasite Ov-16 antigen, with reported sensitivities of only 60–80%. As control programs move from control to elimination, it is imperative to identify novel molecules that could improve the serodiagnosis reli...

Descripción completa

Detalles Bibliográficos
Autores principales: Shintouo, Cabirou Mounchili, Ghogomu, Stephen Mbigha, Shey, Robert Adamu, Hotterbeekx, An, Yagmur, Emel, Mets, Tony, Vanhamme, Luc, Colebunders, Robert, Souopgui, Jacob, Njemini, Rose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703281/
https://www.ncbi.nlm.nih.gov/pubmed/34947815
http://dx.doi.org/10.3390/life11121284
_version_ 1784621425530765312
author Shintouo, Cabirou Mounchili
Ghogomu, Stephen Mbigha
Shey, Robert Adamu
Hotterbeekx, An
Yagmur, Emel
Mets, Tony
Vanhamme, Luc
Colebunders, Robert
Souopgui, Jacob
Njemini, Rose
author_facet Shintouo, Cabirou Mounchili
Ghogomu, Stephen Mbigha
Shey, Robert Adamu
Hotterbeekx, An
Yagmur, Emel
Mets, Tony
Vanhamme, Luc
Colebunders, Robert
Souopgui, Jacob
Njemini, Rose
author_sort Shintouo, Cabirou Mounchili
collection PubMed
description The current serological test for human onchocerciasis relies on IgG4 reactivity against the parasite Ov-16 antigen, with reported sensitivities of only 60–80%. As control programs move from control to elimination, it is imperative to identify novel molecules that could improve the serodiagnosis reliability of this disease. In this study we compared the sensitivity of total IgG against OvMANE1—a chimeric antigen previously identified as a potential biomarker of human onchocerciasis—with that of an Ov-16 antibody test to detect an Onchocerca volvulus infection in persons presenting with microfilaria in skin snips. One hundred and ninety serum samples were obtained from persons with epilepsy in an onchocerciasis-endemic area at Ituri in the Democratic Republic of Congo where ivermectin has never been distributed. Fifty-nine (31.1%) samples were from individuals with a positive skin snip test; 41 (69.5%) of these 59 samples were positive with the OvMANE1 test and 41 (69.5%) with the Ov-16 test; 30 (50.8%) samples were positive for both tests and in 52 (88.1%) at least one of the tests was positive. Testing the 131 sera from persons with a negative skin snip result revealed that 63 (48.1%) were positive exclusively with the OvMANE1 test, 13 (9.9%) exclusively with the Ov-16 test and 25 (19.1%) with both tests. Nine European samples from individuals without past travel history in onchocerciasis endemic zones and 15 samples from Rwanda, a hypoendemic country for onchocerciasis were all negative for the OvMANE1 and Ov-16 tests. However, the specificity of both tests was difficult to determine due to the lack of a gold standard for antibody tests. In conclusion, the tandem use of OvMANE1 and Ov-16 tests improves the sensitivity of detecting Onchocerca volvulus seropositive individuals but, the OvMANE1 test needs to be further evaluated on samples from a population infected with other helminths to cautiously address its specificity.
format Online
Article
Text
id pubmed-8703281
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87032812021-12-25 Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis Shintouo, Cabirou Mounchili Ghogomu, Stephen Mbigha Shey, Robert Adamu Hotterbeekx, An Yagmur, Emel Mets, Tony Vanhamme, Luc Colebunders, Robert Souopgui, Jacob Njemini, Rose Life (Basel) Article The current serological test for human onchocerciasis relies on IgG4 reactivity against the parasite Ov-16 antigen, with reported sensitivities of only 60–80%. As control programs move from control to elimination, it is imperative to identify novel molecules that could improve the serodiagnosis reliability of this disease. In this study we compared the sensitivity of total IgG against OvMANE1—a chimeric antigen previously identified as a potential biomarker of human onchocerciasis—with that of an Ov-16 antibody test to detect an Onchocerca volvulus infection in persons presenting with microfilaria in skin snips. One hundred and ninety serum samples were obtained from persons with epilepsy in an onchocerciasis-endemic area at Ituri in the Democratic Republic of Congo where ivermectin has never been distributed. Fifty-nine (31.1%) samples were from individuals with a positive skin snip test; 41 (69.5%) of these 59 samples were positive with the OvMANE1 test and 41 (69.5%) with the Ov-16 test; 30 (50.8%) samples were positive for both tests and in 52 (88.1%) at least one of the tests was positive. Testing the 131 sera from persons with a negative skin snip result revealed that 63 (48.1%) were positive exclusively with the OvMANE1 test, 13 (9.9%) exclusively with the Ov-16 test and 25 (19.1%) with both tests. Nine European samples from individuals without past travel history in onchocerciasis endemic zones and 15 samples from Rwanda, a hypoendemic country for onchocerciasis were all negative for the OvMANE1 and Ov-16 tests. However, the specificity of both tests was difficult to determine due to the lack of a gold standard for antibody tests. In conclusion, the tandem use of OvMANE1 and Ov-16 tests improves the sensitivity of detecting Onchocerca volvulus seropositive individuals but, the OvMANE1 test needs to be further evaluated on samples from a population infected with other helminths to cautiously address its specificity. MDPI 2021-11-23 /pmc/articles/PMC8703281/ /pubmed/34947815 http://dx.doi.org/10.3390/life11121284 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shintouo, Cabirou Mounchili
Ghogomu, Stephen Mbigha
Shey, Robert Adamu
Hotterbeekx, An
Yagmur, Emel
Mets, Tony
Vanhamme, Luc
Colebunders, Robert
Souopgui, Jacob
Njemini, Rose
Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
title Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
title_full Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
title_fullStr Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
title_full_unstemmed Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
title_short Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
title_sort tandem use of ovmane1 and ov-16 elisa tests increases the sensitivity for the diagnosis of human onchocerciasis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703281/
https://www.ncbi.nlm.nih.gov/pubmed/34947815
http://dx.doi.org/10.3390/life11121284
work_keys_str_mv AT shintouocabiroumounchili tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis
AT ghogomustephenmbigha tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis
AT sheyrobertadamu tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis
AT hotterbeekxan tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis
AT yagmuremel tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis
AT metstony tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis
AT vanhammeluc tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis
AT colebundersrobert tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis
AT souopguijacob tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis
AT njeminirose tandemuseofovmane1andov16elisatestsincreasesthesensitivityforthediagnosisofhumanonchocerciasis